ACLU files suit to eliminate FDA restrictions on abortion-inducing drugs intended to protect women

By Dave Andrusko

On the never-allow-a-crisis-to-go-to-waste front, the ACLU has filed a new suit challenging the protections the FDA has maintained for the use of chemical (“medication”) abortions.

The same people who never tire of criticizing pro-lifers for “exploiting” the COVID-19 pandemic are unceasingly attempting to obliterate the guardrails the FDA has installed to protect women from a “procedure” that has cost dozens of women their lives and been associated with multiple thousands of “adverse events,” including serious infections, severe hemorrhage, and the rupture of previously undiscovered ectopic pregnancies.

Unable to appreciate the irony, the ACLU press release begins, “At a time when we should all be looking out for one another’s health and safety, many of our leaders are focused on restricting abortion access in the pandemic instead.”

The Abortion Industry’s objective is to make access to mifepristone, one of the drugs that make up the two-drug “medication” abortion protocol, easy to get—the end goal being to have it sent through the mail making possible “Do-It-Yourself” abortions. 

Thus, in the ACLU’s cross-hairs is what’s the FDA calls a “risk evaluation and mitigation strategy.” Under R.E.M.S., as Patrick Adams writes, “mifepristone can be dispensed only in clinics, medical offices and hospitals; only by, or under the supervision of, a doctor certified to prescribe the drug; and only to patients who have signed an F.D.A.-approved patient agreement.”

Pro-life leaders both in and out of Congress have written the FDA to stand resolute and to also seize websites selling abortion drugs illegally in the United States and to investigate illegal internet sales of abortion-inducing drugs.

Rep. Bob Latta (R-OH) led 38 Senators and 121 House Members sent a letter to the FDA that read in part

“Despite claims that medication abortion is safe and easy, research proves that as many as five to seven percent of women who take abortion drugs will require follow-up surgery, and three percent could end up in the emergency room. Self-managed abortions from home are especially dangerous; in fact, half of abortion providers do not consider them safe, according to a 2019 survey published in the journal Contraception. Further, medication abortion becomes even more dangerous in situations where women cannot access emergency medical care. This is especially concerning during the COVID-19 pandemic as emergency rooms are currently being overwhelmed.”

National Right to Life joined more than four dozen pro-life and pro-family groups in a letter sent to the U.S. Food and Drug Administration asking the FDA to take action against the illegal sale of abortion-inducing drugs.

“Internet sales of mifepristone have the potential to multiply the inherent dangers of the drug combination, further endangering women’s lives which are already at risk in the abortion procedure,” said Carol Tobias, president of National Right to Life.

“Mifepristone puts at risk perfectly healthy mothers who are pregnant with perfectly healthy babies,” said Tobias. “No woman’s life should be placed at risk because abortion activists are trying to score political points.”